PERIPHERAL NERVOUS SYSTEM AGENTS
Clinical trials for PERIPHERAL NERVOUS SYSTEM AGENTS explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL NERVOUS SYSTEM AGENTS trials appear
Sign up with your email to follow new studies for PERIPHERAL NERVOUS SYSTEM AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a ketamine mist lift severe depression fast?
Symptom relief Recruiting nowThis study tests whether inhaling ketamine through a nebulizer can quickly reduce symptoms of moderate to severe depression in hospitalized adults. About 40 participants will receive either ketamine or a placebo (midazolam) and be monitored for changes in depression scores over 8…
Matched conditions: PERIPHERAL NERVOUS SYSTEM AGENTS
Phase: PHASE3 • Sponsor: Theresa Jacob, PhD, MPH • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
NIH launches study to uncover clues in mood disorder treatments
Knowledge-focused Recruiting nowThis study follows 500 adults already receiving care for depression, bipolar disorder, or suicide risk at the NIH. Researchers will conduct weekly interviews and optional tests like blood draws and brain scans to track symptoms and treatment responses. The goal is to better under…
Matched conditions: PERIPHERAL NERVOUS SYSTEM AGENTS
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC